Nectar Lifesciences Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nectar Lifesciences has submitted a routine compliance certificate to NSE and BSE, as required under SEBI's Depository Regulations. The certificate was issued by Kfin Technologies, the company's Registrar and Share Transfer Agent (RTA), for the quarter ended June 30, 2025. It confirms that all dematerialization requests received from depository participants during the quarter were properly processed and accepted/rejected. The accepted shares have been listed on the stock exchanges, physical certificates have been cancelled, and the register of members has been updated with the depository as the registered owner. This is a standard quarterly housekeeping filing with no business or financial details disclosed.
This is a routine regulatory compliance filing with no material impact on the company's operations, financials, or shareholders. No effect on stock price is expected.